United States Transdermal Scopolamine Market Report 2017

January 2018 | 97 pages | ID: UDC1634C6DEEN
QYResearch

Abstracts

In this report, the United States Transdermal Scopolamine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Transdermal Scopolamine in these regions, from 2012 to 2022 (forecast).

United States Transdermal Scopolamine market competition by top manufacturers/players, with Transdermal Scopolamine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Baxter International Inc.
• GlaxoSmithKline plc
• Novartis AG
• Perrigo Company plc.
• Caleb Pharmaceuticals, Inc.
• Myungmoon Pharma Co. LTD.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Tablet Type
• Syrups Type
• Injections Type
• Patch Type
• Gel Type

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Ambulance Center
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Transdermal Scopolamine Market Report 2017

1 TRANSDERMAL SCOPOLAMINE OVERVIEW

1.1 Product Overview and Scope of Transdermal Scopolamine
1.2 Classification of Transdermal Scopolamine by Product Category
  1.2.1 United States Transdermal Scopolamine Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Transdermal Scopolamine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Tablet Type
  1.2.4 Syrups Type
  1.2.5 Injections Type
  1.2.6 Patch Type
  1.2.7 Gel Type
1.3 United States Transdermal Scopolamine Market by Application/End Users
  1.3.1 United States Transdermal Scopolamine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Ambulance Center
  1.3.5 Others
1.4 United States Transdermal Scopolamine Market by Region
  1.4.1 United States Transdermal Scopolamine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Transdermal Scopolamine Status and Prospect (2012-2022)
  1.4.3 Southwest Transdermal Scopolamine Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Transdermal Scopolamine Status and Prospect (2012-2022)
  1.4.5 New England Transdermal Scopolamine Status and Prospect (2012-2022)
  1.4.6 The South Transdermal Scopolamine Status and Prospect (2012-2022)
  1.4.7 The Midwest Transdermal Scopolamine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Transdermal Scopolamine (2012-2022)
  1.5.1 United States Transdermal Scopolamine Sales and Growth Rate (2012-2022)
  1.5.2 United States Transdermal Scopolamine Revenue and Growth Rate (2012-2022)

2 UNITED STATES TRANSDERMAL SCOPOLAMINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Transdermal Scopolamine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Transdermal Scopolamine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Transdermal Scopolamine Average Price by Players/Suppliers (2012-2017)
2.4 United States Transdermal Scopolamine Market Competitive Situation and Trends
  2.4.1 United States Transdermal Scopolamine Market Concentration Rate
  2.4.2 United States Transdermal Scopolamine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Transdermal Scopolamine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES TRANSDERMAL SCOPOLAMINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Transdermal Scopolamine Sales and Market Share by Region (2012-2017)
3.2 United States Transdermal Scopolamine Revenue and Market Share by Region (2012-2017)
3.3 United States Transdermal Scopolamine Price by Region (2012-2017)

4 UNITED STATES TRANSDERMAL SCOPOLAMINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Transdermal Scopolamine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Transdermal Scopolamine Revenue and Market Share by Type (2012-2017)
4.3 United States Transdermal Scopolamine Price by Type (2012-2017)
4.4 United States Transdermal Scopolamine Sales Growth Rate by Type (2012-2017)

5 UNITED STATES TRANSDERMAL SCOPOLAMINE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Transdermal Scopolamine Sales and Market Share by Application (2012-2017)
5.2 United States Transdermal Scopolamine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES TRANSDERMAL SCOPOLAMINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Baxter International Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Transdermal Scopolamine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Baxter International Inc. Transdermal Scopolamine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GlaxoSmithKline plc
  6.2.2 Transdermal Scopolamine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GlaxoSmithKline plc Transdermal Scopolamine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Novartis AG
  6.3.2 Transdermal Scopolamine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Novartis AG Transdermal Scopolamine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Perrigo Company plc.
  6.4.2 Transdermal Scopolamine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Perrigo Company plc. Transdermal Scopolamine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Caleb Pharmaceuticals, Inc.
  6.5.2 Transdermal Scopolamine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Myungmoon Pharma Co. LTD.
  6.6.2 Transdermal Scopolamine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Myungmoon Pharma Co. LTD. Transdermal Scopolamine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview

7 TRANSDERMAL SCOPOLAMINE MANUFACTURING COST ANALYSIS

7.1 Transdermal Scopolamine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Transdermal Scopolamine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Transdermal Scopolamine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Transdermal Scopolamine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES TRANSDERMAL SCOPOLAMINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Transdermal Scopolamine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Transdermal Scopolamine Sales Volume Forecast by Type (2017-2022)
11.3 United States Transdermal Scopolamine Sales Volume Forecast by Application (2017-2022)
11.4 United States Transdermal Scopolamine Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Transdermal Scopolamine
Figure United States Transdermal Scopolamine Market Size (Units) by Type (2012-2022)
Figure United States Transdermal Scopolamine Sales Volume Market Share by Type (Product Category) in 2016
Figure Tablet Type Product Picture
Figure Syrups Type Product Picture
Figure Injections Type Product Picture
Figure Patch Type Product Picture
Figure Gel Type Product Picture
Figure United States Transdermal Scopolamine Market Size (Units) by Application (2012-2022)
Figure United States Sales Market Share of Transdermal Scopolamine by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Ambulance Center Examples
Table Key Downstream Customer in Ambulance Center
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Transdermal Scopolamine Market Size (Million USD) by Region (2012-2022)
Figure The West Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Transdermal Scopolamine Sales (Units) and Growth Rate (2012-2022)
Figure United States Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Transdermal Scopolamine Market Major Players Product Sales Volume (Units) (2012-2017)
Table United States Transdermal Scopolamine Sales (Units) of Key Players/Suppliers (2012-2017)
Table United States Transdermal Scopolamine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Transdermal Scopolamine Sales Share by Players/Suppliers
Figure 2017 United States Transdermal Scopolamine Sales Share by Players/Suppliers
Figure United States Transdermal Scopolamine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Transdermal Scopolamine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Transdermal Scopolamine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Transdermal Scopolamine Revenue Share by Players/Suppliers
Figure 2017 United States Transdermal Scopolamine Revenue Share by Players/Suppliers
Table United States Market Transdermal Scopolamine Average Price (K USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Transdermal Scopolamine Average Price (K USD/Unit) of Key Players/Suppliers in 2016
Figure United States Transdermal Scopolamine Market Share of Top 3 Players/Suppliers
Figure United States Transdermal Scopolamine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Transdermal Scopolamine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Transdermal Scopolamine Product Category
Table United States Transdermal Scopolamine Sales (Units) by Region (2012-2017)
Table United States Transdermal Scopolamine Sales Share by Region (2012-2017)
Figure United States Transdermal Scopolamine Sales Share by Region (2012-2017)
Figure United States Transdermal Scopolamine Sales Market Share by Region in 2016
Table United States Transdermal Scopolamine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Transdermal Scopolamine Revenue Share by Region (2012-2017)
Figure United States Transdermal Scopolamine Revenue Market Share by Region (2012-2017)
Figure United States Transdermal Scopolamine Revenue Market Share by Region in 2016
Table United States Transdermal Scopolamine Price (K USD/Unit) by Region (2012-2017)
Table United States Transdermal Scopolamine Sales (Units) by Type (2012-2017)
Table United States Transdermal Scopolamine Sales Share by Type (2012-2017)
Figure United States Transdermal Scopolamine Sales Share by Type (2012-2017)
Figure United States Transdermal Scopolamine Sales Market Share by Type in 2016
Table United States Transdermal Scopolamine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Transdermal Scopolamine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Transdermal Scopolamine by Type (2012-2017)
Figure Revenue Market Share of Transdermal Scopolamine by Type in 2016
Table United States Transdermal Scopolamine Price (K USD/Unit) by Types (2012-2017)
Figure United States Transdermal Scopolamine Sales Growth Rate by Type (2012-2017)
Table United States Transdermal Scopolamine Sales (Units) by Application (2012-2017)
Table United States Transdermal Scopolamine Sales Market Share by Application (2012-2017)
Figure United States Transdermal Scopolamine Sales Market Share by Application (2012-2017)
Figure United States Transdermal Scopolamine Sales Market Share by Application in 2016
Table United States Transdermal Scopolamine Sales Growth Rate by Application (2012-2017)
Figure United States Transdermal Scopolamine Sales Growth Rate by Application (2012-2017)
Table Baxter International Inc. Basic Information List
Table Baxter International Inc. Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Baxter International Inc. Transdermal Scopolamine Sales Growth Rate (2012-2017)
Figure Baxter International Inc. Transdermal Scopolamine Sales Market Share in United States (2012-2017)
Figure Baxter International Inc. Transdermal Scopolamine Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc Transdermal Scopolamine Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline plc Transdermal Scopolamine Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline plc Transdermal Scopolamine Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Novartis AG Transdermal Scopolamine Sales Growth Rate (2012-2017)
Figure Novartis AG Transdermal Scopolamine Sales Market Share in United States (2012-2017)
Figure Novartis AG Transdermal Scopolamine Revenue Market Share in United States (2012-2017)
Table Perrigo Company plc. Basic Information List
Table Perrigo Company plc. Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Perrigo Company plc. Transdermal Scopolamine Sales Growth Rate (2012-2017)
Figure Perrigo Company plc. Transdermal Scopolamine Sales Market Share in United States (2012-2017)
Figure Perrigo Company plc. Transdermal Scopolamine Revenue Market Share in United States (2012-2017)
Table Caleb Pharmaceuticals, Inc. Basic Information List
Table Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Sales Growth Rate (2012-2017)
Figure Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Sales Market Share in United States (2012-2017)
Figure Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Revenue Market Share in United States (2012-2017)
Table Myungmoon Pharma Co. LTD. Basic Information List
Table Myungmoon Pharma Co. LTD. Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Myungmoon Pharma Co. LTD. Transdermal Scopolamine Sales Growth Rate (2012-2017)
Figure Myungmoon Pharma Co. LTD. Transdermal Scopolamine Sales Market Share in United States (2012-2017)
Figure Myungmoon Pharma Co. LTD. Transdermal Scopolamine Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Transdermal Scopolamine
Figure Manufacturing Process Analysis of Transdermal Scopolamine
Figure Transdermal Scopolamine Industrial Chain Analysis
Table Raw Materials Sources of Transdermal Scopolamine Major Players/Suppliers in 2016
Table Major Buyers of Transdermal Scopolamine
Table Distributors/Traders List
Figure United States Transdermal Scopolamine Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure United States Transdermal Scopolamine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Transdermal Scopolamine Price (K USD/Unit) Trend Forecast (2017-2022)
Table United States Transdermal Scopolamine Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Transdermal Scopolamine Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Transdermal Scopolamine Sales Volume (Units) Forecast by Type in 2022
Table United States Transdermal Scopolamine Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Transdermal Scopolamine Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Transdermal Scopolamine Sales Volume (Units) Forecast by Application in 2022
Table United States Transdermal Scopolamine Sales Volume (Units) Forecast by Region (2017-2022)
Table United States Transdermal Scopolamine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Transdermal Scopolamine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Transdermal Scopolamine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources